Newsletter Tool

Featured Story

With Delta variant surging, FDA hustles to grant Pfizer's COVID-19 vaccine a full approval: reports

By Kevin Dunleavy

The FDA has accelerated its process to grant full approval to the Pfizer-BioNTech COVID-19 vaccine, installing an unofficial deadline of Labor Day, according to the New York Times.

KFF survey: Majority of unvaccinated adults think shot is riskier than contracting COVID-19

By Robert King

A new survey from Kaiser Family Foundation found a slight majority of unvaccinated adults believe getting the COVID-19 vaccine is riskier than the virus itself.

Pitt's inhalable anti-COVID nanobodies, inspired by llamas, 'remarkably active' against Delta variant: study

By Arlene Weintraub

A University of Pittsburgh team studied tiny anti-COVID antibodies derived from llamas to determine how effective they might be at fighting emerging variants, including Delta. They discovered that the drugs, called nanobodies, can disarm the virus and its variants using any of three different pathways.

With supply problems solved, Novavax inks deal to supply Europe with up to 200M COVID-19 vaccines

By Kevin Dunleavy

After delaying a COVID-19 vaccine supply agreement to Europe because of production problems, Novavax has finalized the deal, which will provide the EU with 200 million doses.

COVID-19 tracker: WHO calls for a booster moratorium; Tuberculosis vaccine could help severe patients

By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner

The World Health Organization has called for a booster shot moratorium through at least September in an effort to provide COVID-19 vaccines to poor, supply-strapped nations. Researchers in India have found that a century-old tuberculosis vaccine could help those with severe COVID-19. Plus more.

Survey: Roughly 1 in 7 people got low acuity care via telehealth instead of going to ER

By Robert King

A new survey found that about one in seven patients got low acuity care via telehealth rather than going to the emergency department as Congress mulls permanent flexibilities.

How a century-old tuberculosis vaccine may help fight severe COVID-19

By Angus Liu

A research group in India has found that the century-old tuberculosis vaccine BCG may have potential for controlling severe COVID-19 in elderly patients by reducing blood levels of proinflammatory cytokines. It's not the first time scientists have proposed repurposing BCG in other diseases.

COVID-19 Tracker